Cargando…
Soluble and Membranous Vascular Endothelial Growth Factor Receptor-2 in Pregnancies Complicated by Pre-Eclampsia
PURPOSE: There is a paucity of information on the serum soluble vascular endothelial growth factor receptor-2 (sVEGFR-2) concentrations, membranous VEGFR-2 expression and the mechanism involved in their modulations during the clinical onset of pre-eclampsia. This cross-sectional study was conducted...
Autores principales: | Tripathi, Richa, Rath, Gayatri, Ralhan, Ranju, Saxena, Sunita, Salhan, Sudha |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Yonsei University College of Medicine
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768240/ https://www.ncbi.nlm.nih.gov/pubmed/19881969 http://dx.doi.org/10.3349/ymj.2009.50.5.656 |
Ejemplares similares
-
Monocytes and Macrophages in Pregnancy and Pre-Eclampsia
por: Faas, Marijke M., et al.
Publicado: (2014) -
Expression analysis of E-cadherin, Slug and GSK3β in invasive ductal carcinoma of breast
por: Prasad, Chandra P, et al.
Publicado: (2009) -
Evaluation of Hematological Parameters in Partial Exchange and Packed Cell Transfusion in Treatment of Severe Anemia in Pregnancy
por: Salhan, Sudha, et al.
Publicado: (2012) -
Proteinuria as a predictor of complications of pre-eclampsia
por: Hofmeyr, G Justus, et al.
Publicado: (2009) -
Prospective assessment of neurodevelopment in children following a pregnancy complicated by severe pre-eclampsia
por: Warshafsky, Chelsie, et al.
Publicado: (2016)